MGMT and brain neoplasm: Although administration of ddTMZ regimens causes more pronounced depletion of MGMT in peripheral blood mononuclear cells [9], the effects of ddTMZ on MGMT activity in brain tumor tissue and its impact on clinical outcome remain unclear.